Active Management Study
T. Rowe Price equity and fixed income strategies delivered higher average returns than their benchmarks 75% of the time. Plus, they beat their benchmark more frequently—and with better returns—than the average of all active managers. Dive into our active management composite study and learn more about how we achieved this.
See below for standardized returns and other information about the T. Rowe Price composites in this analysis.
Our strategies delivered higher average returns than their benchmark over time. Plus, they beat their benchmark more frequently—and with better returns—than the average of all active managers.
Limiting investors' losses is just as important as—and goes hand in hand with—delivering growth. Our experience and approach have allowed us to both identify potential long-term winners and limit losses in the U.S. market in a variety of economic environments. In both up and down markets our U.S. equity strategies delivered higher average returns than their benchmarks over time – that’s the T. Rowe Price difference.
Our fixed income strategies also delivered higher average returns than their benchmark as they too benefit from our rigorous global research and independent thinking, leading to fresh insights. Our investment professionals collaborate to develop better questions for better decisions, knowing that identifying risks is as important as identifying opportunities.
The outperformance of our strategies stemmed from our experience and our commitment to rigorous global research, uncovered opportunities with strong return potential and a low risk of defaults and downgrades. Our flexible process enables us to explore the full capital structure, identifying high-conviction ideas by rating class, industry, and issuer.
The outperformance in our equity strategies stemmed from our experience and commitment to rigorous global research, which allowed us to uncover equity investment opportunities with long-term growth potential.
More return. More often.
That's the T. Rowe Price difference.
Past performance is no guarantee of future results.
Head of Global Equity Josh Nelson and Head of Global Equity Research Jay Nogueira recently discussed how the T. Rowe Price US Structured Research Strategy is a great example of how our collaborative culture and in-depth research inform our decision-making and help us in seeking to generate alpha for clients, both for the strategy itself and beyond.
See below for standardized returns and other information about the T. Rowe Price composites in this analysis.
View standardized returns and other information about the T. Rowe Price composites in this analysis.
Analysis by T. Rowe Price. Represents a comparison of all marketable institutional equity and fixed income composites compared with the official composite primary benchmark assigned to each. Excludes money market, asset allocation, and index/passive composites. In order to avoid double-counting in the analysis, specialized composites viewed as substantially similar to strategies already included (e.g. constrained strategies, ex-single country excluded strategies, etc.) are also excluded. Composite net returns are calculated using the highest applicable separate account fee schedule for institutional clients. An aggregated view of 10-year rolling monthly periods net returns from 1/1/06 to 12/31/25 is shown. All figures in USD.
All Strategies
182 composites covering 8,184 rolling 10- year periods
2415 composites covering 41,109 rolling 10 - year periods. The assets under management (AUM) as of 12/31/25 across all composites considered in the analysis are aggregated and those composites offered by the largest five firms determined by total AUM, identified via eVestment, other than T. Rowe Price, are grouped together here. Source: Nasdaq’s eVestment Analytics database.
36,750 composites covering 603,299 rolling 10-year periods. Source: Nasdaq’s eVestment Analytics database.
Equity Strategies
153 composites covering 5,677 rolling 10-year periods.
2281 composites covering 27,592 rolling 10-year periods. The assets under management (AUM) as of 12/31/25 across all composites considered in the analysis are aggregated and those composites offered by the largest five firms determined by total AUM, identified via eVestment, other than T. Rowe Price, are grouped together here. Source: Nasdaq’s eVestment Analytics database.
34,606 composites covering 410,401 rolling 10-year periods. Source: Nasdaq’s eVestment Analytics database.
US Equity Strategies
133 composites covering 3,857 rolling 10-year periods.
2150 composites covering 15,520 rolling 10-year periods. The assets under management (AUM) as of 12/31/25 across all composites considered in the analysis are aggregated and those composites offered by the largest five firms determined by total AUM, identified via eVestment, other than T. Rowe Price, are grouped together here. Source: Nasdaq’s eVestment Analytics database.
32,181 composites covering 213,332 rolling 10-year periods. Source: Nasdaq’s eVestment Analytics database.
Fixed Income Strategies
129 composites covering 2,507 rolling 10-year periods.
2179 composites covering 18,177 rolling 10-year periods. The assets under management (AUM) as of 12/31/24 across all composites considered in the analysis are aggregated and those composites offered by the largest five firms determined by total AUM, identified via eVestment, other than T. Rowe Price, are grouped together here. Source: Nasdaq’s eVestment Analytics database.
32,144 composites covering 192.898 rolling 10-year periods. Source: Nasdaq’s eVestment Analytics database.
High Yield Strategies
13 composites covering 174 rolling 10-year periods.
29 composites covering 1006 rolling 10-year periods. The assets under management (AUM) as of 12/31/25 across all composites considered in the analysis are aggregated and those composites offered by the largest five firms determined by total AUM, identified via eVestment, other than T. Rowe Price, are grouped together here. Source: Nasdaq’s eVestment Analytics database.
3156 composites covering 14,116 rolling 10-year periods. Source: Nasdaq’s eVestment Analytics database.
202507-4634091